364 related articles for article (PubMed ID: 16493030)
1. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin.
Luci C; Hervouet C; Rousseau D; Holmgren J; Czerkinsky C; Anjuère F
J Immunol; 2006 Mar; 176(5):2749-57. PubMed ID: 16493030
[TBL] [Abstract][Full Text] [Related]
2. Langerhans cells prime IL-17-producing T cells and dampen genital cytotoxic responses following mucosal immunization.
Hervouet C; Luci C; Rol N; Rousseau D; Kissenpfennig A; Malissen B; Czerkinsky C; Anjuère F
J Immunol; 2010 May; 184(9):4842-51. PubMed ID: 20351191
[TBL] [Abstract][Full Text] [Related]
3. B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit.
Sun JB; Flach CF; Czerkinsky C; Holmgren J
J Immunol; 2008 Dec; 181(12):8278-87. PubMed ID: 19050244
[TBL] [Abstract][Full Text] [Related]
4. CD4⁺ T-cell immunity in the female genital tract is critically dependent on local mucosal immunization.
Marks E; Helgeby A; Andersson JO; Schön K; Lycke NY
Eur J Immunol; 2011 Sep; 41(9):2642-53. PubMed ID: 21681740
[TBL] [Abstract][Full Text] [Related]
5. Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses.
Anjuère F; George-Chandy A; Audant F; Rousseau D; Holmgren J; Czerkinsky C
J Immunol; 2003 Feb; 170(3):1586-92. PubMed ID: 12538724
[TBL] [Abstract][Full Text] [Related]
6. Influence of mucosal adjuvants on antigen passage and CD4+ T cell activation during the primary response to airborne allergen.
Wikstrom ME; Batanero E; Smith M; Thomas JA; von Garnier C; Holt PG; Stumbles PA
J Immunol; 2006 Jul; 177(2):913-24. PubMed ID: 16818746
[TBL] [Abstract][Full Text] [Related]
7. HMGB1 released from intestinal epithelia damaged by cholera toxin adjuvant contributes to activation of mucosal dendritic cells and induction of intestinal cytotoxic T lymphocytes and IgA.
Wakabayashi A; Shimizu M; Shinya E; Takahashi H
Cell Death Dis; 2018 May; 9(6):631. PubMed ID: 29795370
[TBL] [Abstract][Full Text] [Related]
8. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.
Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J
J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433
[TBL] [Abstract][Full Text] [Related]
9. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
Sun JB; Czerkinsky C; Holmgren J
J Immunol; 2012 Feb; 188(4):1686-97. PubMed ID: 22250081
[TBL] [Abstract][Full Text] [Related]
10. MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants.
Simmons CP; Mastroeni P; Fowler R; Ghaem-maghami M; Lycke N; Pizza M; Rappuoli R; Dougan G
J Immunol; 1999 Dec; 163(12):6502-10. PubMed ID: 10586042
[TBL] [Abstract][Full Text] [Related]
11. Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development.
Eriksson K; Fredriksson M; Nordström I; Holmgren J
Infect Immun; 2003 Apr; 71(4):1740-7. PubMed ID: 12654787
[TBL] [Abstract][Full Text] [Related]
12. CD11c(high )dendritic cells are essential for activation of CD4+ T cells and generation of specific antibodies following mucosal immunization.
Fahlén-Yrlid L; Gustafsson T; Westlund J; Holmberg A; Strömbeck A; Blomquist M; MacPherson GG; Holmgren J; Yrlid U
J Immunol; 2009 Oct; 183(8):5032-41. PubMed ID: 19786541
[TBL] [Abstract][Full Text] [Related]
13. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions.
Sun JB; Cuburu N; Blomquist M; Li BL; Czerkinsky C; Holmgren J
Scand J Immunol; 2006 Sep; 64(3):251-9. PubMed ID: 16918694
[TBL] [Abstract][Full Text] [Related]
14. Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with non-replicating antigens.
Bowen JC; Nair SK; Reddy R; Rouse BT
Immunology; 1994 Mar; 81(3):338-42. PubMed ID: 8206507
[TBL] [Abstract][Full Text] [Related]
15. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.
Kozlowski PA; Williams SB; Lynch RM; Flanigan TP; Patterson RR; Cu-Uvin S; Neutra MR
J Immunol; 2002 Jul; 169(1):566-74. PubMed ID: 12077289
[TBL] [Abstract][Full Text] [Related]
16. Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.
Kato H; Fujihashi K; Kato R; Yuki Y; McGhee JR
J Immunol; 2001 Mar; 166(5):3114-21. PubMed ID: 11207263
[TBL] [Abstract][Full Text] [Related]
17. Sublingual 'oral tolerance' induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells.
Sun JB; Czerkinsky C; Holmgren J
Scand J Immunol; 2007; 66(2-3):278-86. PubMed ID: 17635805
[TBL] [Abstract][Full Text] [Related]
18. Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice.
Rask C; Holmgren J; Fredriksson M; Lindblad M; Nordström I; Sun JB; Czerkinsky C
Clin Exp Allergy; 2000 Jul; 30(7):1024-32. PubMed ID: 10848926
[TBL] [Abstract][Full Text] [Related]
19. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo.
Porgador A; Staats HF; Faiola B; Gilboa E; Palker TJ
J Immunol; 1997 Jan; 158(2):834-41. PubMed ID: 8993001
[TBL] [Abstract][Full Text] [Related]
20. Suppression of an already established tumor growing through activated mucosal CTLs induced by oral administration of tumor antigen with cholera toxin.
Wakabayashi A; Nakagawa Y; Shimizu M; Moriya K; Nishiyama Y; Takahashi H
J Immunol; 2008 Mar; 180(6):4000-10. PubMed ID: 18322209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
